Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-12

Clinical Trial Update: Non-interventional Study, Long Term Treatment on Glabellar Lines With Dysport® in Subjects of Chinese Origin

View source ↗

Summary

This non-interventional study of Dysport for glabellar lines in Chinese-origin subjects has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Galderma R&D | Conditions: Glabellar Lines | Status: COMPLETED | Results posted: 2025-02-12